Fiche publication


Date publication

août 2022

Journal

Anaesthesia, critical care & pain medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PESSAUX Patrick


Tous les auteurs :
Collange O, Lopez M, Lejay A, Pessaux P, Ouattara A, Dewitte A, Rimmele T, Girardot T, Arnaudovski D, Augustin P, Chakfe N, Tacquard C, Oulehri W, Zieleskiewicz L, Severac F, Leone M, Mertes PM

Résumé

Early diagnosis and prompt management of acute mesenteric ischaemia (AMI) are key to survival but remain extremely difficult, due to vague and non-specific symptoms. Serum lactate (SL) is commonly presented as a useful biomarker for the diagnosis or prognosis of AMI. The aim of our study was test SL (1) as a diagnostic marker and (2) as a prognostic marker for AMI.

Mots clés

Diagnosis, prognosis, Intensive care, Lactate, Mesenteric vascular occlusion, Multiple organ failure

Référence

Anaesth Crit Care Pain Med. 2022 08 12;41(6):101141